Chemours Co Aktie
22,15 €
Deine Einschätzung
Chemours Co Aktie
Was spricht für und gegen Chemours Co in den nächsten Jahren?
Pro
Kontra
Rendite von Chemours Co im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Chemours Co | -0,36 % | -1,47 % | 3,36 % | -35,98 % | -23,88 % | -19,16 % | 31,02 % |
Albemarle Corp | -1,70 % | -5,63 % | -4,43 % | -56,41 % | -37,39 % | -47,48 % | 27,09 % |
Quaker Chemical Corp. | -2,86 % | 7,59 % | 11,11 % | -3,41 % | -13,71 % | -13,71 % | 3,54 % |
Axalta Coating Systems Ltd. | -3,05 % | -1,85 % | -1,24 % | 8,90 % | 4,61 % | 33,78 % | 18,90 % |
Kommentare
News
![Chemours (CC) Q4 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeSt3V1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9dfca4603c1fc3af5c96a68f8938e1fa8ce6aed8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/featured-transcript-logo-template-2023-01-12.jpg?locale=de)
Chemours (CC) Q4 2023 Earnings Call Transcript
Image source: The Motley Fool.
Chemours (NYSE: CC)Q4 2023 Earnings CallMar 28, 2024, 8:00 a.m. ET
Operator
Source Fool.com
![Why Chemours Stock Is Plunging Today: https://g.foolcdn.com/editorial/images/770991/engineers-examining-equipment-source-getty.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL3hqYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b07b105d1905df2afd27c868dc692be61a3e3aa3/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/engineers-examining-equipment-source-getty.jpg?locale=de)
Why Chemours Stock Is Plunging Today
Chemours (NYSE: CC) surpassed top- and bottom-line quarterly expectations, but investors are more focused on the drama going on behind the scenes. Shares of Chemours traded down 15% as of 10 a.m. ET
![Why Chemours Stock Soared Today: https://g.foolcdn.com/editorial/images/768490/calculator-with-financial-statements.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMVZPYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--96ab717f1f899f2b43fde329b420e4f13df7cc75/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/calculator-with-financial-statements.jpg?locale=de)
Why Chemours Stock Soared Today
Shares of Chemours (NYSE: CC) rallied 16.8% today after the chemical company concluded an internal review that's loomed over the business for the past week, finding that that three top executives